The knowledge about HMGB1 as an inflammatory mediator gained during the last decade after its rediscovery is mainly based on results from experimental studies, with models of sepsis and endotoxemia in particular. The gene discussed is HMGB1; the disease is serum lipopolysaccharide activity.